Aesthetic devices maker Ulthera won a new U.S. patent for an ultrasound-based therapy for treating sweat glands disorders, such as hyperhidrosis
The patent, titled "Methods for treatment of sweat glands" was granted by the U.S. Patent & Trademark Office late last week, according to a press release.
"This new patent adds a significant asset to the patent portfolio for Ulthera, which has rights to over 100 U.S. and international patents that are issued, published or pending," president & CEO Matthew Likens said in prepared remarks. "The groundbreaking advances underlying this patent are a result of many years of collaboration between Ulthera and Guided Therapy Systems, LLC, a global innovator of ultrasound-based technology."
Ulthera’s recent study showed that 3% of the general population is "profoundly affected" by hyperhidrosis and many more consider themselves "sweat-bothered," Likens added.
“The potential to treat a medical condition and positively impact a patient’s quality of life is a logical progression for our platform technology," he said.
It’s the 2nd recent win for privately held Arizona-based Ulthera, maker of the 1st ultrasound based technology for non-invasively tightening skin.
Earlier this month Ulthera won FDA clearance for its Ulthera System, an energy-based platform device designed to non-invasively "tighten turkey necks and smooth out double-chins."